-
Most Popular
Search Results
240 results for icgn
OCGN Stock Falls Despite Positive FDA Update
Shares of the biotech company are falling despite news that the FDA has cleared it to resume clinical trials of its Covid-19 vaccine.
OCGN Stock Alert: Why Is Ocugen Gaining Today?
Ocugen’s stock is up more than 5% after the latest clinical trial results showed its Covid-19 vaccine booster shot had positive results.
General Electric Stock Is Back to Being an American Icon
GE stock is back to being an American icon but it still has a long way back to old glory. With time, this team will…
The Reasons to Avoid OCGN Stock Keep Piling Up
OCGN stock got a bump on Phase 3 results but was met with market skepticism following its subsequent strategic moves.
OCGN Stock: What to Know as Ocugen Soars Today
With ink drying on its deal with Bharat Biotech, Covid-19 vaccine stock Ocugen ended the week on a strong bullish note.
Iconic Luxury Retailer Henri Bendel Closing for Good
Henri Bendel, a luxury retailer based in NYC, is closing its doors for good as owner L Brands (LB) looks to save some money.
5 Stephen Hawking Quotes to Remember the Iconic Physicist
Stephen Hawking passed away early on Wednesday morning while at his home in Cambridge and ‘InvestorPlace’ is remembering him with some quotes.
Solid Earnings Growth Keep Icon (ICLR) a Buy
Currently, Icon Plc (NASDAQ:ICLR) has a Buy using the approach to investing of Louis Navellier and his Portfolio Grader stock evaluator. ICLR has maintained this…
Icon (ICLR) Raised to Strong Buy from a Buy
Icon Plc (NASDAQ:ICLR) ranks in the upper half of its industry group, Life Sciences Tools & Services, and in the top 25% of its sector…
Ringling Brothers Circus to Phase Out Iconic Elephants
The Ringling Brothers Circus, announced on Thursday, that it won’t have elephant acts by 2018 as it phases the animals out of its shows.
Icon Plc (ICLR) Stock is Cultivating a Strong Business
Icon Plc has seen strong growth since its inception in 1990, and ICLR stock is promising, if still a little risky.
3 Iconic American Brands Destined for the Trash Heap
The economic downturn — and in some cases, just good, old-fashioned obsolescence — is taking a toll on these three American mainstays.
How Buffett & 6 Other Icons Fared in 2010
Who had a better year on Wall Street — Warren Buffett, Carl Icahn or Jim Cramer?
Why You Should Keep Your Distance from Ocugen Stock
Off and on the price chart OCGN stock, today’s reality is bleak for shareholders, but being a bear poses its own challenges.
Don’t Play the Ocugen Stock Short Squeeze Before You Read This Warning!
While the contrarian bullish argument for OCGN stock has picked up considerable chatter, this is an extremely risky trade.
Entry Into Infectious Disease Field Creates Opportunity for Ocugen
Now that Ocugen is collaborating to develop a Covid-19 vaccine, OCGN stock holders should brace for a possible regulatory authorization.
The Vaccine Deal Boost Can’t Keep Ocugen Stock Afloat
No one wants to be the bearer of bad news, but we must acknowledge that the vertical move in OCGN stock is turning out to…
Is Ocugen Worth a Shot Because of the Worsening Pandemic?
While OCGN stock seems like a reasonable speculation based on the worsening Covid-19 crisis, it’s still a tough gamble.
Ocugen Has a Longer Road To Paying off Than People Think
Ocugen seems to have delivered good news in recent days, yet OCGN stock is right back where it started. Does that create a buying opportunity?
Despite an 80% Drop, Ocugen Stock Is Still Too Pricey
Until the hype surrounding its Covid-19 vaccine candidate is no longer priced into shares, it’s best to avoid OCGN stock.
It’s Time To Drop Ocugen Stock While You Still Can
Hope is one thing, but for investors in OCGN stock expecting regulators or other bulls to come to the rescue is looking less likely
3 – 10 of 240 results
